Company intelligence / Profile preview

Genomics plc

Oxford, Oxfordshire, United Kingdomgenomics.com ↗

Ownership: Private
Employees: ~150
Development stage: Commercial

Overview

Genomics plc has developed a leading platform for predicting individual absolute disease risks using large-scale genomic data. Their technology enables personalized health insights, early intervention strategies, and supports pharmaceutical partners in target identification and clinical trial optimization. The company collaborates with major pharma companies such as Vertex to advance precision medicine. Clinical results pertain primarily to validation of their predictive algorithms rather than traditional therapeutic trials.

Therapeutic areas: Metabolic Disorders
Modalities: Polygenic risk scoresGenetic data analytics
Industry: Molecular Diagnostics

Partnerships

Vertex Pharmaceuticals (multi-year collaboration announced August 2018)

Beyond the preview

Go deeper on Genomics plc.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Genomics plc.

Explore the full profile